<SEC-DOCUMENT>0000950170-22-026739.txt : 20221219
<SEC-HEADER>0000950170-22-026739.hdr.sgml : 20221219
<ACCEPTANCE-DATETIME>20221219161610
ACCESSION NUMBER:		0000950170-22-026739
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221215
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221219
DATE AS OF CHANGE:		20221219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		221471257

	BUSINESS ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		7209402200

	MAIL ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>abio-20221215.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2022-12-19T10:53:09.5334+00:00 --><!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:abio="http://www.arcabiopharma.com/20221215">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_e7284e4f-3154-45f0-a449-e085e1e8a16f" name="dei:EntityCentralIndexKey" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522">0000907654</ix:nonNumeric><ix:nonNumeric id="F_efab4ae6-d945-4bbb-adfb-c79edc963114" name="dei:AmendmentFlag" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="abio-20221215.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000907654</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-15</xbrli:startDate><xbrli:endDate>2022-12-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c20a825-5d71-48bb-847d-8da8d854a6bf" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): December 19, 2022 (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0f639c8b-f987-428d-b00c-a1ac3e1f8136" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 15, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d983bf6e-998f-4434-9e87-7928db2e4d77" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_360aa211-1ddd-47b3-b4a4-6f43ac2e0d36" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f59536b4-6f78-498e-8fd7-c27ecf60bb42" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-22873</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d24bd859-ac61-4932-bd6f-9436399f155c" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-3855489</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_483eee89-caf5-41cc-ad53-5bf42bfbdd04" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10170 Church Ranch Way</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_94bd81bb-2e3e-4d66-84ae-346a420d65aa" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_56464c71-f4bc-4725-8fc3-7b842ff2b364" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Westminster</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_11bed576-57c6-4fa5-863c-265ba00d0c59" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Colorado</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e0626a2e-7fbd-4dc6-b969-edd0f948d34c" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80021</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ab988334-b6fe-4f32-aca5-58e976a7198d" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(720)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7eb7e016-41e8-4848-b5e3-b6a5624cb3fb" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">940-2200</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_73cb0e37-d8e5-4b4b-972e-eb976f27bafc" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e71686a1-cdde-4923-832a-d852216dee84" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bc5514fd-6dbd-4d73-98c3-7de626d3d316" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3df5c7d8-47a0-4bb9-a94a-ae1e7739157b" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b39fc1d1-ee3c-4539-8807-50292c7b7950" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a28e6e39-6f6f-4e00-8b55-8dfd29e4efd1" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ABIO</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b355b627-3c64-4f28-a840-def23bbb2227" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The NASDAQ Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_d1d61e6b-9d77-47c0-992d-7edc6008bb51" contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 15, 2022, the Board of Directors (the &#x201c;Board&#x201d;) of ARCA biopharma, Inc. (the &#x201c;Company&#x201d;) elected James Flynn, as a director of the Company. Mr. Flynn was elected for a term expiring at the Company&#x2019;s 2025 annual stockholders&#x2019; meeting. A copy of the press release announcing Mr. Flynn&#x2019;s appointment is attached hereto as Exhibit 99.1, the contents of which are incorporated herein by reference.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mr. Flynn is currently a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. Nerium Capital LLC is the General Partner of Nerium Partners LP, a healthcare focused investment partnership. Mr. Flynn also currently serves as a Board Member for Axiom Health, a provider of software and big-data solutions to the healthcare industry, since 2022, and has been an advisor to the company since 2020. From 2017 to 2018, Mr. Flynn worked as a therapeutics analyst at Aptigon Capital (a Citadel Company), an investment firm. Prior to that, from 2003 to 2017, Mr. Flynn served in various roles at Amici Capital, LLC, an investment firm, including healthcare portfolio manager (2008 to 2017). From 2002 to 2003, Mr. Flynn worked in the credit research/high yield group at Putnam Investments, an investment firm. Mr. Flynn earned a S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology (MIT). Mr. Flynn is a Chartered Financial Analyst (CFA) charterholder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, the Company entered into a Cooperation Agreement with Cable Car Capital LLC and its affiliates that includes, among other terms, customary standstill provisions and the right for Cable Car to nominate an additional director nominee at the Company&#x2019;s 2022 Annual Stockholder Meeting. The Company and Cable Car initiated a process and subsequently identified a mutually acceptable second independent director, Mr. Flynn, to join the Company&#x2019;s Board of Directors. Mr. Flynn was elected as Director at the 2022 annual meeting of stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 15, 2022, pursuant to the Company&#x2019;s Director Compensation Policy, the Company also granted Mr. James Flynn an option to purchase 12,000 shares of common stock at an exercise price of $2.32 per share, the closing price of the Company&#x2019;s common stock on The NASDAQ Capital Market on December 15, 2022.  The option is subject to the terms and conditions of the Company&#x2019;s 2020 Equity Incentive Plan (the &#x201c;Plan&#x201d;) and the Company&#x2019;s standard forms of Stock Option Agreement and Option Grant Notice under the Plan. The option vests in 36 equal monthly installments beginning on December 15, 2022, assuming Mr. Flynn&#x2019;s continued service on the Board for such periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On the same day, the Company also approved paying compensation to its existing non-employee directors, pursuant to the Company&#x2019;s Director Compensation Policy, by granting to Dr. Linda Grais, Dr. Anders Hove, Mr. Robert Conway, Mr. Daniel Mitchell, Dr. Raymond Woosley and Mr. Jacob Ma-Weaver options to purchase 6,000 shares of common stock at an exercise price of $2.32 per share, the closing price of the Company&#x2019;s common stock on December 15, 2022.  The options are subject to the terms and conditions of the Plan and the Company&#x2019;s standard forms of Stock Option Agreement and Option Grant Notice for the Plan.  The options vest in 12 equal monthly installments beginning on December 15, 2022, assuming Dr. Grais&#x2019;, Dr. Hove's, Mr. Conway&#x2019;s, Mr. Mitchell&#x2019;s, Dr. Woosley&#x2019;s and Mr. Ma-Weaver's continued service on the Board for such periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.07 Submission of Matters to a Vote of Security Holders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 15, 2022, the Company held the 2022 Annual Meeting at which the Company&#x2019;s stockholders voted upon (i) the election of Company nominees, Drs. Linda Grais and Anders Hove and Mr. James Flynn, to the  Board for a three-year term ending at the 2025 Annual Meeting of Stockholders, (ii) the ratification of the selection of KPMG LLP as the Company&#x2019;s independent registered public accounting firm for the fiscal year ending December 31, 2022 and (iii) the approval of, on an advisory basis, the compensation of the Company&#x2019;s named executive officers as disclosed in the Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The stockholders elected the director nominees, ratified the selection of KPMG LLP as the Company&#x2019;s independent registered public accounting firm for the fiscal year ending December 31, 2022, and approved the resolution concerning the advisory vote on the compensation of the Company&#x2019;s named executive officers.  The tabulation of votes cast with respect to each matter voted upon, as applicable, was as follows:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Election of Directors:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:28.674%;"></td>
    <td style="width:13.104%;"></td>
    <td style="width:9.461%;"></td>
    <td style="width:10.618%;"></td>
    <td style="width:11.282%;"></td>
    <td style="width:11.604%;"></td>
    <td style="width:4.318%;"></td>
    <td style="width:10.94%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nominee</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Withheld</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Broker Non-Votes</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dr. Linda Grais</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,625,386</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">192,401</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,296,871</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dr. Anders Hove</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,331,324</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">486,463</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,296,871</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mr. James Flynn</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,616,593</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">201,194</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,296,871</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Ratification of the selection of KPMG LLP as the Company&#x2019;s independent registered public accounting firm for the fiscal year ending December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:23.792%;"></td>
    <td style="width:15.006%;"></td>
    <td style="width:10.92%;"></td>
    <td style="width:10.145%;"></td>
    <td style="width:9.944%;"></td>
    <td style="width:14.996%;"></td>
    <td style="width:15.197%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Against</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Abstentions</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Broker Non-Votes</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,980,366</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116,906</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,386</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Executive Compensation:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:23.873%;"></td>
    <td style="width:15.076%;"></td>
    <td style="width:10.88%;"></td>
    <td style="width:10.497%;"></td>
    <td style="width:9.742%;"></td>
    <td style="width:15.076%;"></td>
    <td style="width:14.855%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Against</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Abstentions</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Broker Non-Votes</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,301,245</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">456,787</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,755</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,296,871</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.139%;"></td>
    <td style="width:10.12%;"></td>
    <td style="width:78.741%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="abio-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Press Release titled &#x201c;James Flynn Joins ARCA biopharma Board of Directors&#x201d; dated December 19, 2022</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the inline XBRL document).</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Registrant)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 19, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ C. Jeffrey Dekker</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: C. Jeffrey Dekker<br />Title: Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>abio-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><img src="img123434494_0.jpg" alt="img123434494_0.jpg" style="width:203px;height:69px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JaMES FLYNN joins arca biopharma board of directors</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Westminster, CO, December 19, 2022</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#x2013; </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Nasdaq: ABIO) today announced that James Flynn has joined its Board of Directors.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;We are pleased to welcome James Flynn to our Board,&#x201d; said Robert E. Conway, Chairman of ARCA&#x2019;s Board of Directors. &#x201c;We appreciate his participation and input on the Company&#x2019;s Board of Directors, including our process for evaluating strategic options for the Company.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mr. Flynn is currently a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. Nerium Capital LLC is the General Partner of Nerium Partners LP, a healthcare focused investment partnership. Mr. Flynn also currently serves as a Board Member for Axiom Health, a provider of software and big-data solutions to the healthcare industry, since 2022, and has been an advisor to the company since 2020. From 2017 to 2018, Mr. Flynn worked as a therapeutics analyst at Aptigon Capital (a Citadel Company), an investment firm. Prior to that, from 2003 to 2017, Mr. Flynn served in various roles at Amici Capital, LLC, an investment firm, including healthcare portfolio manager (2008 to 2017). From 2002 to 2003, Mr. Flynn worked in the credit research/high yield group at Putnam Investments, an investment firm. Mr. Flynn earned a S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology (MIT). Mr. Flynn is a Chartered Financial Analyst (CFA) charterholder.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:16.8pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, the Company entered into a Cooperation Agreement with Cable Car Capital LLC and its affiliates that includes, among other terms, customary standstill provisions and the right for Cable Car to nominate an additional director nominee at the Company&#x2019;s 2022 Annual Stockholder Meeting. The Company and Cable Car initiated a process and subsequently identified a mutually acceptable second independent director, Mr. Flynn, to join the Company&#x2019;s Board of Directors. Mr. Flynn was elected as Director at the 2022 annual meeting of stockholders.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">About ARCA biopharma</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma is dedicated to developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. At present, ARCA is evaluating options for development of its assets, including partnering and other strategic options. For more information, please visit </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">www.arcabio.com</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investor &amp; Media Contact:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jeff Dekker</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">720.940.2122</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ir@arcabio.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">###</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img123434494_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img123434494_0.jpg
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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MY=0K*P&<9PP!Q[UQ]%%% C:HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
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M-(<]QN)Q[ 5G-V5CIP\>:5^P5XW^T)XD\NWL=#B?YI#]IG _NC(0?B=Q_P"
MBO8I)%B1G=@J*,EB< #UKY)\:>(&\4>)[_4228Y9"(@>T8X4?D!^.:X3]L#P
M%_PFWP8U&XACWWVBL-2BQUV(")1]/++-]5%?G!7[$75K%>VLUO/&LL$R&.2-
MAD,I&"#[$5^3WQ.\%R_#SX@:]X=E#?\ $ONGCC9^KQ'YHV/^\A4_C2IOH7B(
MZJ1O_!GQ!_8?C>VC=ML%\/LK_P"\>4/_ 'T /Q-?3-?%\4KP2I)&Q21&#*PZ
M@CH:^N_"VMIXD\.Z?J28_P!(B5F"] _1A^# C\*YBBBBM3C-6BBBBBBB@ HH
MHHHHHH ******** "BBBBOM?]D7X4_#[QM\*3<:MI&GZUK+7DHN?M(#2PA2-
MBCG*KMP>V2QKXHIT<C0NKHQ1U.0RG!!J6KFD)*+NU<*\,^,7B[Q'H?BX1V=Y
M<V-B(4\KRN$<G.2?4YR/PKW.FLH92K ,#P0:_3Z3]FGX82(R'P9IP##!VAP?
MS#9%9EW^R/\ ">\SN\)K&VW:&BOKE,>^!)C/U%? WAOXT^._"+(=*\6ZM;(A
MRL+7321?]^WROZ5]"?";]NK48;ZWL/'MI%=6;D*=6L8]DL?^U)&/E8>NT*0.
MQZ5GRR74ZXU:<M&CY77XH>*E8$:W<Y'K@C^56H?C%XNAZ:N6&<X>"(Y_\=KZ
M$U/P/H&L*WVO1[.5FZN(@K_]]#!_6O.?%_P#MI()+CP_,\4ZC(LYVW(WLK'D
M'ZY^HKUVX_8I^%TSADT^_@&,;8[Z0CZ_-DU0D_87^&[R,PEUN,$Y"K>)@>W,
M9-?0-K=0WUK#<VTJ7%O,BR12QL&5U(R&!'4$$<U-4<S[G1[.'8XZ/XY>*XUP
MUS;R'/5K=?Z8JPOQ[\3*H!2Q8CN83D_^/5YU-"]O,\4J-'(C%61A@J1P01ZT
MROGZW_8>^&<*;7CU:<YSNDO<'Z?*H%:EG^QK\*+;'F>'Y[KY=O[[4+@9/K\K
MCG].>E>VUXE^T1^TQ8?!)+?3;2S75O$EU'YJ6[OMB@CR0'D(Y.2#A1@G!Y'&
M2\F3*-.*NT>B2?'CQ0[9#6<8]%@X_4U5F^-?BZ3.W4(XN<_);1_ERIKA:[KX
M;_"^X\=-)<S3&STR)MC2*,O(W4JOX8Y/KT-;-K^RW\++,@Q^#K1L#;^]EFD_
M]"<\^]7(?V<?AE#('7P7I9*_WXBP_(G%?#OB+]KCXH^()G(\1?V9"W(@T^WC
MB5?HV"_YL:Y.X^.7Q$NMN_QSXA7;T\O4ID_/:PS6G++N8>VI](E*7XK^+)L[
MM:F'.?E1%_DM0/\ $SQ3(I4ZY= ?[+X/YBO>--^#OA33D _LW[5(.LES(S$_
MAG'Z5KQ^ _#<6=N@Z:<_WK5&_F*_0N;]FWX8SE]W@S3!OSG8C+U],$8_"L#5
MOV._A5JBML\/RZ?(?^6EI?3 C\&9E_2OB/2_VC/B9H\BO!XUU:0J !]JF^T#
MCU$@8'\:]F^&_P"WEK>GW$-MXTTR'5;(D!K[3U$5P@[DIG8_T&RERR74:J4I
M:-'SBGQ.\51[<:W=';_>(/YY'-:-G\:/%MJPW:BMPH_AF@0C\P ?UKW6Z^&O
MA>\4K)H=FH/_ #Q3RS^:XKB?$W[/]C<1O+H=U):3XR+>X.^,^V[[P_6NN\5?
M\$_]&N%=_#GB>]L7ZK#J4*3J3Z;DV$#\#7S_ /$;]EKX@_#A)+BXTG^U].3D
MWNDDSHH]67 =1[E<>]?HSX0\8Z/X\T&WUG0K^+4=.G'RRQGH>ZL.JL.X/(K9
MI*;1<J,)+0Q])_:(O8RHU+2H)UZ%[5S&?K@[L_F*]#\-_%CP[XF98X[S['<M
MT@O (R?H<[3^!S7S5K.BWOA_4)++4+=K:YCZHW<>H/<>XJE7XY45^B?QR_9-
M\._$ZWN-2T6*'0/$Y!83Q+MM[EO25 ."?[ZC//.[I7P#XI\+:IX+UZ\T76K.
M2PU&T?9+#(.GH0>A!&""."#D5K&2D<52FZ>Y]IT5\V^ OB_J7A62.UOG?4=*
MR 8V.9(AZH3_ .@GCZ5]#:3JUIKFGPWUC,MQ;3#<CK_(^A'I651115&1<HHH
MHHHHH ******** "BBBBBBKVAZ'J'B;5K;3-*LYK_4+E]D5O;H6=S[#]2>P&
M: "BBJ]_?V^EV<MU=S);V\0W/)(< "J-=K\._@UXP^*5P$\.Z+/=0!MKWLG[
MNWC]<R-@9]AD^U?5/P5_8BT_1X[?5O'Q74[_ (=='A?_ $>(\'$C#_6'V'R]
M?O"OJ>QL;;2[.&TL[>*TM85"100($1%'0*HX ]A64I]CKAAV]9%BL+Q)XVT;
MPG'NU*^CADQE8%^:1OHHY_'I7DOCCXZW-XTEGX>!M;?[IO'7]X_^Z#]T>YY^
ME>3W%Q+=3/-/(\TSG<\DC%F8^I)ZFOD_P#^P+IUJL=QXQUZ6]FX)LM*'EQ#V
M,C LP^BJ?>O?/"?P)\ >"0ATGPIIL4J?=N)XO/F!]I)-S#\#6[XU\=Z%\.]#
MEU?Q!J,6G6,? :0Y9VQPJ*.6;V KXT^*W[<VO:[)-8^"K;^P=/SM%_<*LEU(
M/4 Y6/\ \>/N*CWI'0_9TNAZ[X@_:%N92T>BZ>D"=!/=G<WU"@X'XDUY]K'C
M[Q%KF[[9J]RZ-UCC?RT_[Y7 K/T/0+_Q)?I9Z=;/<SMV7HH]2>@'N:]L\(_
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M7Z[^'O%FB>+;7[3HFKV.K6_>2RN$E ]CM)P?8UJLH92" 01@@]Z_'[2M8O\
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MTU#EI+I^;"BBBMZ*?WJY#<=.:P8;BL[6/%AL[F/3=/1;O5YN$BS\L0Q]]SV
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M(=(CC\JR:<W5H!T\F3YU ]ER5_X":\[K[3_;Z\ _:=)T'QC;Q9>V<Z==L!_
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MT/P;U)FQB76YG7'IY,"_S4U$]CIP_P 85\Z_'ZW$/CB)P/\ 6V<;G_OIU_\
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MN[RXENKJ9C)+/,Y=W8G)9F/))]34*-G<WG4YXI=CYB^,'AY?#_C>Z\I-EO>
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M?R/1AAI4Y*46%%%%4]-TVYUB]BM+2(RSR'"J/YGT%>K:#X#L?#L*RW 6\O\
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MG[J^<OB?R:^9YM65.&E./S?^6P44459T70;/3Y!,%:XN\8-U<L9)??D]![#
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ML<<GS-L^@_A#X=_X1_P19[UVW%Y_I4F1S\P&T?\ ?(7]:[6FJHC4*H"JHP%
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M["\__H$5?1-<TMSUJ?P(^=?C[_R/,?\ UYQ_^A/7FU>D_'W_ )'F/_KSC_\
M0GKS:BORO^/G_):_&_\ V%[C_P!#-?JA7Y7_ !\_Y+7XW_["]Q_Z&:NGN88G
MX4%?67P]_P"1&T+_ *\X_P#T$5\FU]9?#W_D1M"_Z\X__017!4445L<!T-%%
M%%%%% !11117Z3?L@Z"^A_ 3P^9!MEO6FO&7'9I&"_FJJ?QK\]O O@^^^('B
M[2O#VFION]0G6)3CA%ZLY]E4%C[ U^L6AZ/;>'=%T_2K)/+M+&WCMH4]$10J
MC\@*RJ/H=F'CJY!7S%\9=0%_\0=1"G*P!(0?HHS^I/Y5]&Z]K5OX>T>[U&Z;
M;#;QES[GLH]R<#\:^0[^\EU*^N+N=MTT\C2NWJS')_G5ZF331VT,DTTBQ11J
M7>1R JJ!DDD]!3Z^4?VROV@8=%TFX\ Z!<K)J=XFW5)XFS]GA/\ RQR/XW'7
MT4X_BXR2N['9*2@KL@IT<;2R*B*7=CA549)/H*;7KGP4^';WUY'XAU"(K:PG
M-I&P_P!8X_C^@[>_TY^6OC?X^_X69\4M?\01DFTGG\NU[?N$ 2,X[$JH8^Y-
M<+1174>0W=W9ZQX$\/?\(OX3T[3F'[Z./=+_ -=&.YOR)Q^%;]%%%%%% @HH
MHK[1_8#\"+#IGB'QA/'^]FD&F6S$<A%"O*1[$F,?\ -?7E>;?LX^%QX1^"7A
M*QV[99+);R7UWS$RD'W&_'X5Z37-)W9ZU./+!(\/_:&U\O=:=HJ-\D:_:I1G
MN<JOY -_WU7CE=/\3-5.L>.M8GSE5G,*^F$^3C_OG/XUS%%?%/[?WC5KC7/#
MGA.&3]U:PMJ-P@/!=R4CS[A5?\'K[6K\P?VFO$A\3_'3Q=<[BR6]V;)!V A4
M1$#VRA/XU4%J9XB5H6[A7N7[/.AB.QU/5W7YY7%M&Q'(51N;'L25_P"^:\-K
MZI^%VFC2O .C18PTD/GGWWDO_(C\J\PHHHK<\TZJBBBBBBB@ HHHHHHHH **
M****** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******
M** "BBBBG(C2.J(I9F. JC))]*;7M'[)/PZ/C[XQ:;+/%YFFZ-_Q,KC<,J60
MCRE_%RIQW"M2;LKE1CS-)!368*I). .233JX?XP^)/\ A'O!=RL;[;F]_P!&
MCP><$?,?^^<_B17W3\#_ (>K\,/A?H6@E%2\CA$UX1CFX?YI.>^"=H/HHKXI
M_;0\?CQA\8)],@DWV.@Q"R4 _*9C\TK?7)"'_KG7WC\0/&%OX!\$ZWXANL&+
M3[5YPK'&]P,(GU9BJ_C7Y-ZCJ%QJVH75]=RM/=7,K332-U=V)+$_4DUE#5W9
MV8A\L5!'@?CSQ&?%7BK4-0#$PL^R'/:->%^F0,_4FO<O@CX=_L7P9'=2)MN-
M0<SGCG9T0?3&6_X%7S_X=T:3Q#KMCIL6=]S*L9(_A7/S-^ R?PKZ]MK>.SMX
MH(4"11($11T"@8 _*J]?I/\ LD>./^$V^">CB63?>:26TR;/7]WCR_\ R&T?
MX@U^;%?3_P"P;XX_L?X@:KX9FDQ!K%KYL*G_ )[PY.!]8VD)_P!T5<U=&-"7
M+/U):^8OC#H/]A^.KTHNV&\Q=)_P+[W_ (\&KZ=KRK]H#0?MGAVTU1%S)92[
M'/\ TS? _P#0@OYFONZL+QSX4M_''@_6= N\"'4+62W+8^XQ'RM]5.#^%;M%
M<YZ1X#5_0=6ET'6K+48<[[:59,>H!Y'XC(_&J%%?CYJNFW&BZI>:?=QF*[M)
MG@FC/\+JQ5A^!!JK7OW[:G@(^$OB_+JD,6RQUZ$7BD?=\X?)*OUR%8_]=*\!
MKJ6JN>/*/+)H^S;2ZCOK6&YA;?#,BR(WJI&0?RJ:O//@?X@_MCP:EH[;I]/<
MPD=]AY0_S'_ :]#HHHHIDA11111110 44444444 %%%%?:,W4UFW!ZU:O[B2
M'&RVEN,YSY908^NYA6-?:E-%&S_V9=OC^%3$3_Z'7]_U:T:<7>^GDW^2/S6G
M%L****BNFK*N3P:K:AXFFA_Y@6J/QGY8XS_[/7,:EXZNX>1X;U/&.LD9 _0&
MOB<?G."H7]I)K_MV7_R)ZM*A.6R_%!1116W=-UK+N#7(ZA\3+M21_97V<_\
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MBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****_0K]BGX=GP?\
M"G^VKF+R]0\02_:CD886ZY6$'V.7<>T@KX;^&?@FX^(WCS1/#EMN#W]RL;NH
MR4C'S2/_ ,!0,?PK]7]/L+?2M/MK*TB6"UMHEABB4<(B@!0/8 "LJCZ'9AXZ
MN05\Y?'+Q)_;7B[[#$^ZWTY/*Z\>8>7/\A_P&O>/%&N1^&O#]]J<N"+>,LJG
M^)NBK^)('XU\BW%Q)=W$L\SF265R[L>I8G)/YU\M_M[>/_[-\*Z-X1MY<3:E
M-]LNE4\^3&?D!]F<Y_[9U\/5Z?\ M)>/O^%B_&+7M1BD\RQMI/L%ISD>5%E<
MCV9MS_\  Z\PJXJR,*LN:;9ZO^S[X=^U:M>ZQ(GR6J>3$3_?;J1]%X_X%7O%
M<K\,?#__  C7@O3[9UVW$B_:)NQWOS@_08'X5U5%;W@+Q9/X%\::+X@MMWFZ
M==QW!53RZAOF3Z,N5_&L&BJ,]M0K.\0:1'K^AWVG2XVW,+1Y/8D<'\#@_A6C
M17[#6-]!J=C;WEM();:XC66*1>C*P!!_$$5/7AO['/CD^,?@M86LTADO-$D;
M3I-QYV+AHC] C*O_   U[E7*]'8]B,N9)GQA<026MQ)#*I26-BCJ>Q!P14==
MY\:M!_L7QQ<2HNV"^47*XZ;CP_X[@3_P*N#KY^_;6\!?\)9\(7U:"+?>Z#.+
MM2!EO);"2CZ8*N?^N=?GG7[!:OI=MKFDWNFWL?G6=Y ]O-&?XD=2K#\037Y,
M>-O"USX)\7:QH%WGS].NI+9F(QO"L0&'LPP1[&M:;TL<6(CJI'HGP-\0?V/X
MR6S=\0:@AB.3QO'*'^8_X%7T?7QE9W<MA>07,#;)H9%D1O1@<@_F*^OM#U:+
M7='LM0A_U=S$LH&<XR.1]0<C\*Q****U.,OT4444444 %%%%%%%% !1117VA
M-WK.N.]:<PYK.N%ZU_H/+X3\S@%%%%9%S63=5L72]:R[E>M?.8J)Z%,****Q
MKI0V0>16#?:397&?,M(7/JT8S70W*U@ZSJ=KI,)DNI5C!Z+_ !-]!WKXK,HT
M53<Z]N5=[6_$]*DW>T0HHHKG;SPKILF<6_EGU1B*/A3/%HOQ,CMMV8YEDMPQ
M([KN'ZJ!]37.ZWXNGU%FCMP;> \=?F;ZGM^%8^GWTVFWUO>0-MGMY%E1O1E.
M1_*OQ'$9S@,+F5#$X&FOW4U)M*UTGJK>?<]KV,YTI0F]T%%%%?5^H6^<US5_
M;9SQ72Z/JUMXHT.UU.U.8KA-VW/*MT*GW!R/PJG?6><\5_5=>-/%THUZ+O&2
M33[I['Q].3@^66Z"BBBN$O+7KQ6-=66<\5VUY8YSQ63<6'M7PN-R_G;T/5IU
M0HHHKCI+#VI$T_GI72OI^>U(NGX[5\T\I][8ZO;!11163;V6.U5O&1%GX;F!
MX:5EC7\\_P @:ZJ"P/I7GGQ(U9+C4H["%LQVOWR/[Y[?@/YFN'/>3*\JJREO
M)<J]7_DKLN@W5JI=@HHHJ#P_X=L[ZRCGG#2,Q.5#X Y]JZBQ\/:=#C;90GW=
M=W\Z\WT_4[G3)O,@D*GNIY4_45WOA_Q=::@5BG(M;CH Q^5OH?Z&ODN'<;E4
MU&C4IQC4T5VEK\^[[?<=>(A55VG=!11175V5O'" (HTC'^RH%;%K_#6=;KTK
M5MEZ5^XX6"BDDCPJ@4445HV]:UN*S;=>E:MNM?6X5'G5 HHHK1MZ\9_:,_X_
M-"_ZYS?S2O9X.E>,?M'?\?F@_P#7.;^:U\EXA?\ )-XCUA_Z7$Z,L_WN/S_(
M****\<HHHK^/#[D******** "BBBBBBB@ HHHHHHHH *****^U_V"?AW]CT7
M6?&EU%B6\?[!9,PY$2$-*P]F?:/^V9KXSTC2KG7=5L]-LHC->7DR6\,8ZL[,
M%4?F17ZQ?#_P?:^ /!>C>'K,+Y&GVR0;E&-[ 9=\>K,68^YK.;TL=6'C>7-V
M"O#/V@_$GG7UCH<3_)"/M$X!XW'A0?H,G_@0KVR\O(M/LY[F=MD,*-([>B@9
M)KY$\1:U+XBUR]U*;.^YE+X)SM'9?P&!^%9?QEL_$.J?#/7]/\+6PN=<OK<V
ML*M*L057(5VW,1@A"Q'OBOA7_AC+XJ_] .V_\&$'_P 57UE\3/VMO!GPL\7W
M7AS4K36+V_M51IFT^")XT+*&"Y>53G!!Z=ZY;_AOKX??] ?Q+_X"V_\ \?J(
M\R6B-ZGLY/WF6_!,^FVOBC3[G5I?*L8)/.<A"^2O*C '.6 _#->^?\+M\)?\
M_P#+_P" \G^%>0>%_@_K?BS1HM3M9K."WE+!!<2.&.#C. IXR#^5:W_#/?B+
M_G]TO_O[)_\ &Z^=O^&,OBK_ - .V_\ !A!_\51_PQE\5?\ H!VW_@P@_P#B
MJ^B?^&^OA]_T!_$O_@+;_P#Q^C_AOKX??] ?Q+_X"V__ ,?JKR[&7)1[GI/_
M  NWPE_S_P O_@/)_A1_PNWPE_S_ ,O_ (#R?X5YM_PSWXB_Y_=+_P"_LG_Q
MNC_AGOQ%_P _NE_]_9/_ (W7SM_PQE\5?^@';?\ @P@_^*KZ)_9$^%7CSX1W
MGB"P\2Z;':Z1?1QSPR1W4<NV9#M(PK$_,K=>GR"C_AOKX??] ?Q+_P" MO\
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M4'"C\@*W/"/PGUGQEI/]HVDMI!;^8T:_:7=2V,9(PIXR<?@:^1/^&,OBK_T
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M:4&%%%%1-IOM2+IOM5#4OBMX5LD)CO)+QQ_!!"V?S8 ?K7 >)?C%?:DKP:7
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M^Z*+[PG!J"KF2QG&6]$?Y3_X]LKTZN&^,VI6]CX!OXIG42W12*).[-O!./H
M3^%?I'1117,>N?,M%%%?*O[<_P )Y->\/V/C;3H#)=:4OV>_"#DVQ.5?_@#$
MY]G)Z"OAROV'NK6&^M9K:YA2XMYD:.6*10RNI&"I!Z@@GBO@7]H?]DW5?A_?
M76N>%;6;5?"[DR-!$"\]CW(8=6C'.&'0#YO4[0ET9PUZ;OS(]:^ GB]=/U&?
M0KF3;%=GS;<L>!*!@K^( _[Y]Z]YKXOAF>WF26)VCD1@RNIP5(Y!!]:^A?AO
M\7[3Q%!%8:M*EIJJ@*)&(6.?W![-[=^WH/G*BBBM3B/2Z******* "BBBBBB
MMSP9X)UKX@:];Z-H-A+?WTS !8U^5!G!=VZ*H[D\4#WT"BBL_6]<L?#NGRWN
MH7"V]O&.K'ECZ =S["OO#]AVT-O\#8Y#G%QJ5Q(,C'3:O'K]VOH&N2^$_@*+
MX8_#S1/#44BSFQ@VRS*,"25B7D8>Q=FQGMBNMKE>KN>O!<L4F> _'B82>/&7
MC]W:QKU^I_K7G5;'B[Q _BGQ)?ZHRE/M$F40]50 !1]< 5CT5^6O[0UL]K\;
M_&R2##'4YI!]&.X?H17ZE5\3_MI? G5?^$DG\?:+:27VGW42#4HX%+/;R(H4
M2D#^ JJY/8@D]:N#U,<1%RCH%?5_PYE6;P+H97H+5%_$#!_45\H5[E\#_'UI
M_9<?AZ^F6"XB=C:M(<"16.=N?[P)/U!'I7R51116YYI[#11111110 4445+:
M74VGW4-U;2O!<0NLD4L;89&!R&![$$ U^GG[/OQ=A^,7P\M-4=D75[?_ $;4
M8%XVS ?> [*XPP],D=J_+ZO5OV;_ (Q2?!WXAV]W<2-_85_BVU*,<_NR?ED
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M+ZW2>VF2>"0962-@RL/4$55HHHJC,FHHHHHHHH ******** "BBBBO3O@/\
M W5?C5XI6UA$EIHEL0U_J.W*QKUV+V+MV';J>!7:_!']D#Q%\1);?4_$23>'
M/#N0W[U-MU<KZ1H?N@_WV'<$!J^\?"7A'2/ N@6NBZ'8QZ?IUL,)#&.YZL2>
M2Q/))Y-9RE;1'52HN6LM@KE?'_CRT\#Z297*S7THQ;VV>6/]X^BC_P"M6'XZ
M^,NF^&UDM=-9-3U+I\AS%&?]IAU/L/Q(KY_UC6;S7]0EOK^=KBYE.6=OT '8
M>U3>&_#FG>$=!L=&TFV6STZRB$,,*=%4>I[DG))/)))/6OGG]O3Q%_9WPOTC
M2$;$FI:DK,O]Z.)&)_\ 'FCKZ9KX5_;\\0_;?B%X>T97W1V&G&<C/"O+(01]
M=L2'\16<=6=59\M-C-4U*YUC4+B^NY6FNIW+N[=S_0>WM7H_[/NF_:?%5Y>,
M,I:VQ /HS, /T#5Y=7OG[/.F^3X<U*](PUQ<B//JJ*,?JYKY<HHHKH/+/5Z*
M***U?"OAF_\ &7B/3M#TN'S[^_G6"%.V2>I/8 9)/8 FL^UM9KZXBM[>*2>X
ME8)'%&I9G8G   Y))[5][?LG?LW2_#6U_P"$I\20*OB6ZBV6]JW)L8F'.?\
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M_M436_M7%3P,*%.-*"TBK&_M7)W84445C&WKFO&%B)+OP\Q(R-20=,_PL?\
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M;>$9^5KAVD./H,<U[C<01W4,D,J"2*12CJW0@C!%<4GP6\(*Q)TQW']UKF7
M_)J^X_AS\"/!'PL82Z#HD4=_MVG4+@F:X/KAV^[GN%P/:O0*_,2__:A^*6I;
MO-\8WB;NOV>.*'_T!!6%/\;OB'<2;V\<^(@?]C5)T'Y!@*SY'U.GZQ!:)'@_
MB7X@:[XL!34+YFM\Y%O& D?Y#K^.:YVOJ>W^%/A.UQLT6 X_YZ,[_P#H1-7X
M_ OAR-<#0=-(_P!JTC)_45^K%-91(K*RAE88((X(K\I?^%T?$'_H>O$O_@WN
M/_BZO6?[0'Q(L<>5XWUML#'[Z\>7_P!#)H]FP^LKL?)-*K%6!!P1R"*^M_\
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M  A/AW_H :7_ . <?_Q-?JY7G'C[]GGP#\29)+C5_#\"7[Y)OK(FWF)/=BN
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MK_,****]F^STH@%>,?\ #1EQ_P! *+_P)/\ \31_PT=<?] &'_P)/_Q-:?\
M$0N&_P#H(?\ X!/_ .1%_9F+_E_%?YA1117M8A'I3Q#D8(XKQ+_AI"Y_Z 4/
M_@2?_B:7_AI"Y_Z 47_@2?\ XFE_Q$+AS_H(?_@$_P#Y$7]EXO\ E_%?YA11
M17N"QJH&!3Z\,_X:0N?^@%%_X$G_ .)IDG[1]XP'EZ) I_VIV/\ 05#\0N'+
M?[P__ )__(A_9>+_ )?Q04445[M2,P526( '))[5\]7W[0NOW"E;:TL;3/\
M%L9V'YMC]*XG7O'&N^)@5U+4Y[B,\^4"$C_[Y7 _2O$QWB=E-"+^J0E4EZ<J
M^]Z_^2G13R>O)^^TE]X4445[KXT^-ND>'4DM]-9=6U#H/+/[E#_M-W^B_F*\
M \0>(M0\4:E)?:C<-<3MP,\*@[*H["LVBOPSB#BK,>(I6Q,N6FMH+;U?=^;^
M5CZ/"X*EA5[BN^X44444445\<=X44444444 %%%%%%%% !11111110 44444
M444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444
M%%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%
M%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11
M111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111111
M10 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4
M4444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444
M444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444
M%%%%%%%% !11111110 444445K:-X3UCQ P&GZ=<7(/\:IA/Q8\#\Z]*\,_
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M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
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M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
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M &UI$7V>!7"W%NN2JY. R^G/!'3D8IJ5R94915PHHHKR.BBBJ.<********
M"BBBBBBNX\+_  @UWQ)$EP\:Z;:-R)+K(9AZA.OYX%!48N6B"BBBN'HKU_\
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M110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110
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MLC%W9NI).2:SCO<ZZLN6*@@HHHIE%%.BC::1(T7<[D*JCN3T%:'(%%%%>J_
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MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
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M_4+?6I=*%I-)>I(8Q"J$LV#U ]#ZU-X9\6:GX2OOM.FW!B+</&W*2#T9>_\
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MT+^U?& NW7,-A&9>1QO/RJ/U)_X#7M7CSQ(/"GA>]OPP$X7RX >\C<+^77Z
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MBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@
MHHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHH
MHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M ******** "BBBM;PGH;>)/$FGZ<HR)Y0'QV0<L?^^0:^LU58D"J J*, #H
M*\9^ OA.5;BXU^XC*1;##;;A]XD_,P]AC&?<^E>B_$75GT7P3J]W%Q((?+4C
ML7(0'\-V:REJ['=17+!R84445\Z>.-=_X23Q5J5^&W122E8N?^6:_*OZ '\:
MPJ**U.)N[N%%%%%%%% @HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ***
M***** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *******
M* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "B
MBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBB
MBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@
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MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
4 "BBBBBBB@ HHHHHHHH ****_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abio-20221215.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-12-19T10:53:09.0230+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.arcabiopharma.com/20221215" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:abio="http://www.arcabiopharma.com/20221215" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20221215_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20221215_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>abio-20221215_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-12-19T10:53:09.0591+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="abio-20221215.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>abio-20221215_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-12-19T10:53:09.0784+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139691356450976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 15,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARCA biopharma, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000907654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">000-22873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-3855489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10170 Church Ranch Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westminster<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">940-2200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABIO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>abio-20221215_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abio-20221215.xsd" xlink:type="simple"/>
    <context id="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_e7284e4f-3154-45f0-a449-e085e1e8a16f">0000907654</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_efab4ae6-d945-4bbb-adfb-c79edc963114">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_9c20a825-5d71-48bb-847d-8da8d854a6bf">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_0f639c8b-f987-428d-b00c-a1ac3e1f8136">2022-12-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_d983bf6e-998f-4434-9e87-7928db2e4d77">ARCA biopharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_360aa211-1ddd-47b3-b4a4-6f43ac2e0d36">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_f59536b4-6f78-498e-8fd7-c27ecf60bb42">000-22873</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_d24bd859-ac61-4932-bd6f-9436399f155c">36-3855489</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_483eee89-caf5-41cc-ad53-5bf42bfbdd04">10170 Church Ranch Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_94bd81bb-2e3e-4d66-84ae-346a420d65aa">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_56464c71-f4bc-4725-8fc3-7b842ff2b364">Westminster</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_11bed576-57c6-4fa5-863c-265ba00d0c59">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_e0626a2e-7fbd-4dc6-b969-edd0f948d34c">80021</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_ab988334-b6fe-4f32-aca5-58e976a7198d">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_7eb7e016-41e8-4848-b5e3-b6a5624cb3fb">940-2200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_73cb0e37-d8e5-4b4b-972e-eb976f27bafc">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_e71686a1-cdde-4923-832a-d852216dee84">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_bc5514fd-6dbd-4d73-98c3-7de626d3d316">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_3df5c7d8-47a0-4bb9-a94a-ae1e7739157b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_b39fc1d1-ee3c-4539-8807-50292c7b7950">Common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_a28e6e39-6f6f-4e00-8b55-8dfd29e4efd1">ABIO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_b355b627-3c64-4f28-a840-def23bbb2227">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522"
      id="F_d1d61e6b-9d77-47c0-992d-7edc6008bb51">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @  H*353JJHN=  0  / (   \
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    (  *"DU7G*FW4[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  *"
MDU697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @  H*35;8B)<1B!   )1$  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  *"
MDU6?H!OPL0(  .(,   -              "  :4,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @  H*359>*NQS     $P(   L              ( !@0\
M %]R96QS+RYR96QS4$L! A0#%     @  H*353JJHN=  0  / (   \
M         ( !:A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  *"DU4D
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    (  *"DU5ED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="abio-20221215.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="abio-20221215.htm">abio-20221215.htm</File>
    <File>abio-20221215.xsd</File>
    <File>abio-20221215_lab.xml</File>
    <File>abio-20221215_pre.xml</File>
    <File>abio-ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "abio-20221215.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "abio-20221215.htm"
     ]
    },
    "labelLink": {
     "local": [
      "abio-20221215_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abio-20221215_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "abio-20221215.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "abio",
   "nsuri": "http://www.arcabiopharma.com/20221215",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "abio-20221215.htm",
      "contextRef": "C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "abio-20221215.htm",
      "contextRef": "C_8ac55f2e-e05f-4ab5-9cd3-3659117d5522",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-22-026739-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-22-026739-xbrl.zip
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MC\P_1[:'!.;@_/" 3#>@RFW2)SJY3Y(J8V,],:<['V1>@>R[Q[<4K'Z4K=)
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MAGM/G/@3$H@\0'CO[^"7<5&L?"Y)+\H)O"T'#EUA+@2\ZTTQP"VL$2;NT9R
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M]L#I8FUPD^]O/JT@#Z=EK&S%8DH;Q>D7B0^ME4GD?GSHY;GTL]647DL_7ZX
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M]?R433[\Y5UO4 SC#_\/4$L#!!0    (  *"DU483XK_# ,  +,)   1
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M"-];_+@^46=P] <GU_\#4$L#!!0    (  *"DU7T1;_<E 0  'PF   5
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MT3,.REF/S&J"F^!XZ,.2H#.Z#1XNS'R9?>6X.KAAKPO!RWWSQ*1RJ%<)#A7
MC<$C^MHP5&I)Y$1?BN7+;%8(>;%*W=!OPJT5=$R\I02?<]SI1,<C!7@G)K5!
MW<?> O,Y*5G3A6;5PPE&/1K!R?$$>YVDF!6AG1I5#C:16*=LQIM@*HJ8\N65
MX_P-4P.QJ_;L)=]M9*H J]@NAW<8(O=E'A5"\[11^'@2N>>S)CL+*\02VC.]
M!65^6GLF15 4ZJ:]B:+ $PD):[5G.+;MV#IQ%D*HI7VR9\#5?:D 1H0:^]@!
M_D^2\L'M7I'3;JRBD@@YFRRW\=*VT76FR&ZLHC,A>B:O\^[DN3EYSKN0=Y@2
MR/:1=^*:1\F$3%]S-Y/S.8A,87//MI+$1;;R?FFXM)*D1R;PNN$"#U,EF:I?
M&Z[J0JXE$_I;PX4>9V8R9<V]7EY(ZV02?V^LQ--44'8:-'?+O)Q+RE0V]\9Y
M+OF4Z6NN;Y[FK/:JW.;>5(J37GME[>:NNJ*,6>:'S3W@CA)NF1,V-R H2=IE
ML_5]]ZX;ZT09A+S?;J]V!?J?_O72[;]02P,$%     @  H*35>0;>=L1!P
MQ"@   \   !A8FEO+65X.3E?,2YH=&WM6EUOVS@6?=]?<9%@BP2P%=L)VL;V
M!.MFTMT432:8%IC=IP5-41(;B51)*H[WU^\A:<5*D\YT!LW$[01YB$R1O%_G
MGGM)>UJXJCSZ&TT+P5+\IZF3KA1')__N'QXFP^E>_(@)>ZL9T[E.EV%F3=8M
M2_'#EA/7KB]5*I0;#Y+!WR>95JYOY?_$>(C/M9M4S.12]9VNQW$@S,A8)<OE
M^+VLA*5SL:"?=<54.WFNG=/5:GX0P4J9J[&1>>$F6T=3OT>KPISQR]SH1J5]
MKDMMQB:?LYU!+_SM3NZ,#7<GBT(ZT;<UXV)<&]%?&%9'O1;"BQ@K;2I6=HT9
MW=']V<=&N\DG%L3!'EEA9#:I8,M"IJX89])!.^7@)^A_<EW(N704_>PW/9KN
MU1OA65GE9 W_80L/P]'^P?[!P>'!?P?)ASK?(E:Z^U^L=(ZVC@;[]?6DB)Y\
M?HCGK:-GV\/G@\DC&_FAL4YFRT\!]'DT/$#H5^'>"']PB!'F=^936.\,4S9#
MDHR;NA:&,RO^6*+-=9D^F*_?L+.3=_3Z[7_.S^F#ELH2@ZHTE[HN&!*<YIJ9
ME'1&J32".VWLHV3C\'GR\HN0NL%4%]=[-<?2P0C^V:C\(JS#.POH]>CXIQ[]
M*+BHYL+0\+!'H\%HU ;A&S']<X;2L^WKT6"X/Z&N0;_+K,<V8?;S\6R=+STZ
M53RY29'O(T@[Y\RF[..89J].?]HEIU.V)*84K. B)5<P1V^8W_EUN52*"F8#
MF>"==)9>M13R8TLAR1.'?.48Q3SBDU\$"%Q070K4&X1&TT*47%?B5H PK!L3
M ].+2],)6293R 3-.#I)Z%BK!5N"?PHFH;OR$?1@C_,/)_<&EKJ*U/ $E\P)
M*J2EFADGN:R9DUH!/@"'JAM'^. * 7%5S=3RUW;O804OFU2J/.A?&\V%M80J
M2^**E0VVQBN+TNM$+CGIVLN*$SHRDM;D)QA^91B>F60%,02<-\9@N 17T!E3
M+/?!.8MUS(?_0AN7Z5+J^!:C"/8Y]F\J.F:UKY'T]NUQ#Y,1^"M?$[$=L?1*
M0@M"/#/O',\RRA?%87+/:J^(#_T_A1(&0Q= H;HE:C5BZ>T%1&%;M/ %]UF4
M:=[8L/V-\'HUN9!U0FMK66EUQUZHAQ4$&F0K&*_,]D"<74M=T;^"&"\0*+Z2
M:53)ZLPMO&COG[G,^RES#*-E$X&,Q/7&='0$2H$>@SRU2 X1FH->6.Y9>"Z$
M3[7H,Y\$<3V/>;!>,H A!EHA*U[X2?C_LM>Q;Z'-)1P1#,(&0)6 1AP?%2N7
M%D%Q-$.RY4CFUOD[C([QD(JRS;O=3T.9@5@2NC"R58VY'F51D<'^2I$7746"
M9T/ KQB6-9:,+KVK(;\"N[32>_<AQXOK<DC'C?4-%JL5%G>@PLM6A=T;_PQ&
M<6RP?X]_9*0R;D2*HZL15J";+O8*I!XMI2A3\OE<>VTO&J=8A6ZAU<[>[YRU
M#.SE*RJC=\FKA%*1&^'#OTJ>L.0=E\)'="%=@8G(2W]^,9%Q,?6U5,R_]_!@
MA"2&WS%\@HD:WKM9'T+@+3ECUC)>( L<"ODI.E+I&O YH/I>\$*!@O(E[9R=
MOM_MJBH]3E W#!I8J!S%2F!BMH++SO'KV2[Q.*/  4>8IY[@:Y/QJ:(WC6HI
MH5/_*!QJ UZ!941*:YQ0(TIF'E8!3 %$QVQ>8ATSMS@U%&\ @F69+'V!M[$)
MC*DE/)0K[8NTYPJ"K I#X%)XG!G0CL,&\')91O*S@=O\IE[)<,\2F'(M'&IZ
MA"K?2P0Z0WYA$=1ICZ7Q/3(":MS;3G@O '^JP:)W3O/+"#LPL_!=0T+O.P[R
MNJRE2P5I$)U&M@X]AY]AF[D5'YO(^=(#5&8RS*H:!SF^\G$N:A=VL@*A\3Y/
M12T"G&^4[U!)S]OJF^<O;8JZ>;< 08L2XY&KVSFM3X(+6'1!%<T.16?MC75G
MWL7^)H*;-N-2\$]DBP>]!YK--5KQVV?9OYR'_]2; E\DT;M*'H@%29^**U'J
MVB=ECF85[55D$'#&BD?A*!$FAPY,BGBP0?^22GW%+&]*D%6*YAAG/\_(<$]>
M!,[",<R3++(> D&3X6RF4=F#8-/DK73/_ G-G%]C\=R+F("NG0-6]UC56>>Y
M)%0%BW;AUF%MU37[Q[4Y=XYI8#%L6.G0U?J;TU"1>JO#+/DZX;[=>Z+%8I'X
MNU4 ($'__7U=$3U.\_;T[<7F<.>#5J=X2@(Y/&-5/4'+EDK?M2K'N!MO-/2^
MP5Q^(S*TE^+R4IB-=NU?-JM+D=WYAO\WG/'RP7U1F%:5FN6B/S>"7?99AK/?
MF)4+MK18^(2AC<'0]T-7+T:#Y/!@D(R&ZV]%GWS[=7PKS3_N:UF_O5]D;*)S
MM[>W-\.C?Y ;[\K]OKGQ\6O%E]78Z5[\#>)T+_QZ\?]02P$"% ,4    "  "
M@I-5K)]<VI4=  !LFP$ $0              @ $     86)I;RTR,#(R,3(Q
M-2YH=&U02P$"% ,4    "  "@I-5&$^*_PP#  "S"0  $0
M@ '$'0  86)I;RTR,#(R,3(Q-2YX<V102P$"% ,4    "  "@I-5ET5<_K8%
M   O-   %0              @ '_(   86)I;RTR,#(R,3(Q-5]L86(N>&UL
M4$L! A0#%     @  H*35?1%O]R4!   ?"8  !4              ( !Z"8
M &%B:6\M,C R,C$R,35?<')E+GAM;%!+ 0(4 Q0    (  *"DU7D&WG;$0<
M ,0H   /              "  :\K  !A8FEO+65X.3E?,2YH=&U02P4&
/  4 !0!! 0  [3(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
